Adenocarcinoma

"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant epithelial tumor with a glandular organization.

Descriptor ID	D000230
MeSH Number(s)	C04.557.470.200.025
Concept/Terms	Adenocarcinoma Adenocarcinoma Adenocarcinomas Adenoma, Malignant Adenomas, Malignant Malignant Adenoma Malignant Adenomas Carcinoma, Granular Cell Carcinoma, Granular Cell Carcinomas, Granular Cell Granular Cell Carcinoma Granular Cell Carcinomas Adenocarcinoma, Granular Cell Adenocarcinomas, Granular Cell Granular Cell Adenocarcinoma Granular Cell Adenocarcinomas Adenocarcinoma, Tubular Adenocarcinoma, Tubular Adenocarcinomas, Tubular Tubular Adenocarcinoma Tubular Adenocarcinomas Carcinoma, Tubular Carcinomas, Tubular Tubular Carcinoma Tubular Carcinomas Carcinoma, Cribriform Carcinoma, Cribriform Carcinomas, Cribriform Cribriform Carcinoma Cribriform Carcinomas Adenocarcinoma, Basal Cell Adenocarcinoma, Basal Cell Adenocarcinomas, Basal Cell Basal Cell Adenocarcinoma Basal Cell Adenocarcinomas Adenocarcinoma, Oxyphilic Adenocarcinoma, Oxyphilic Adenocarcinomas, Oxyphilic Oxyphilic Adenocarcinoma Oxyphilic Adenocarcinomas

Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]

Below are MeSH descriptors whose meaning is related to "Adenocarcinoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.

Bar chart showing 277 publications over 30 distinct years, with a maximum of 18 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	5	2	7
1997	3	2	5
1998	1	0	1
1999	2	3	5
2000	3	2	5
2001	2	0	2
2002	4	2	6
2003	5	5	10
2004	8	4	12
2005	8	1	9
2006	8	2	10
2007	3	5	8
2008	9	3	12
2009	12	1	13
2010	8	3	11
2011	7	6	13
2012	10	1	11
2013	11	4	15
2014	12	5	17
2015	16	0	16
2016	13	2	15
2017	15	3	18
2018	5	2	7
2019	10	0	10
2020	5	0	5
2021	11	0	11
2022	6	0	6
2023	6	0	6
2024	6	2	8
2025	3	0	3

Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.

Boysen M, Lai SH, Byers S, Widmar M, Loria A, Russell T, Abelson JS, Fleming FJ, Monson JR, Vogel JD. Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination. Ann Surg Oncol. 2026 Apr; 33(4):2856-2864.

View in: PubMed
Zewde MG, Peyser DK, Yu AT, Bonaccorso AM, Moshier EL, Alavi K, Goldstone RN, Marks JH, Maykel JA, McLemore EC, Sands DR, Steele SR, Wexner SD, Whiteford MH, Sylla P. Impact of Obesity on Postoperative Outcomes in Transanal Total Mesorectal Excision for Rectal Cancer. Dis Colon Rectum. 2026 Apr 01; 69(4):553-564.

View in: PubMed
Nasasra A, Mamman R, Hershkovitz Y, Zager Y, Lavy R. [RECTUS ABDOMINIS MASS AS THE FIRST PRESENTATION OF LUNG ADENOCARCINOMA]. Harefuah. 2025 May; 164(5):289-291.

View in: PubMed
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC, Rivard S, Regenbogen S, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch GC, Wise PE. Short-Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium. J Surg Oncol. 2025 Mar; 131(3):498-506.

View in: PubMed
Assouline B, Kahn R, Hodali L, Condiotti R, Engel Y, Elyada E, Mordechai-Heyn T, Pitarresi JR, Atias D, Steinberg E, Bidany-Mizrahi T, Forkosh E, Katz LH, Benny O, Golan T, Hofree M, Stewart SA, Atlan KA, Zamir G, Stanger BZ, Berger M, Ben-Porath I. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice. Nat Commun. 2024 Jul 22; 15(1):6162.

View in: PubMed
Leylek O, Honeywell ME, Lee MJ, Hemann MT, Ozcan G. Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy. Gastric Cancer. 2024 11; 27(6):1201-1219.

View in: PubMed
Mirza MB, Gamboa AC, Irlmeier R, Hopkins B, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Wise PE, Ye F, Idrees K, Hawkins AT, Balch GC, Khan A. Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer. J Surg Res. 2024 08; 300:494-502.

View in: PubMed
Romatoski KS, de Geus SWL, Miriyam B, Chung SH, Kenzik K, Papageorge MV, Rasic G, Ng SC, Tseng JF, Sachs TE. Overall Volume of Upper Gastrointestinal Surgery Positively Impacts Gastric Cancer Outcomes at Centers with Low Gastrectomy Volume. Ann Surg Oncol. 2024 Aug; 31(8):5293-5303.

View in: PubMed
Burks EJ, Sullivan TB, Rieger-Christ KM. Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial. Cancer Biomark. 2025 Jan; 42(1):CBM230452.

View in: PubMed
Schnelldorfer T, Castro J, Goldar-Najafi A, Liu L. Development of a Deep Learning System for Intraoperative Identification of Cancer Metastases. Ann Surg. 2024 Dec 01; 280(6):1006-1013.

View in: PubMed

People

Explore

Similar Concepts

Top Journals